ABIOMED H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ABIOMED is $120,400, based on 104 certified filings from FY 2020 to FY 2026. This is equal to the national H-1B median salary of $120,000. Compensation at ABIOMED reflects their market positioning, with entry-level roles starting around $105,000 and senior positions reaching $161,200 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ABIOMED range from $88,000 at the 10th percentile to $161,200 at the 90th percentile, showing a $73,200 spread across experience levels and roles. The 25th percentile is $105,000 and the 75th percentile is $143,300.

Yes, ABIOMED actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), ABIOMED filed 23 H-1B labor condition applications with 22 certified and 1 denied, at a median salary of $133,400. Across FY 2020–2026, they have filed 111 total H-1B applications with 104 certified and a 0.9% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. ABIOMED sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ABIOMED filed 23 H-1B applications, with 22 certified and 1 denied. Over 7 years of data, ABIOMED has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ABIOMED's LCA (Labor Condition Application) denial rate is 0.9%, with 1 out of 111 applications denied across all years. This translates to a 99.1% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ABIOMED as a potential H-1B sponsor.

This is a good approval rate, comparable to industry averages. ABIOMED demonstrates reliable H-1B sponsorship practices.

ABIOMED sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 104 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ABIOMED most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ABIOMED:

The most frequently sponsored role is Senior QA Engineer with 6 filings at a median salary of $125,000. This is followed by Senior Software Engineer (5 filings) and QA Engineer II.

ABIOMED's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ABIOMED sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ABIOMED H-1B locations:

The largest H-1B hub for ABIOMED is Danvers, MA with 102 filings at a median salary of $120,400. The highest-paying location is Danver, MA at $125,000 median. Salaries range from $117,000 to $125,000 across office locations.

ABIOMED's median H-1B salary has increased by +27% from FY 2020 ($105,000) to FY 2026 ($133,400). Tracking salary trends over time reveals how ABIOMED adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ABIOMED.

Year-by-year breakdown:

• FY 2022: $111,206 (16 certified)
• FY 2023: $120,000 (10 certified)
• FY 2024: $120,400 (13 certified)
• FY 2025: $130,100 (14 certified)
• FY 2026: $133,400 (22 certified)

This 27% growth reflects strong compensation adjustments at ABIOMED, keeping pace with market demands for H-1B talent.

ABIOMED primarily files H-1B applications at Wage Level III, accounting for 37% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ABIOMED's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 91% of positions at Level II or higher, ABIOMED typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ABIOMED's median H-1B salary of $120,400 is equal to the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ABIOMED's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ABIOMED's offerings with similar companies in your field for a more accurate assessment.

ABIOMED's H-1B salaries are competitive with industry averages. The 104 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ABIOMED's higher proportion of Level III-IV positions (60%) may benefit from wage-based lottery prioritization.

With 104 certified filings, ABIOMED invests significantly in H-1B sponsorship. The company's 0.9% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.